NCT03049072Recruiting
Ion Therapy Patient Registry
A Prospective Registry Study to Record Clinical Results and Side Effects of Ion Beam Therapy at MedAustron
Source: ClinicalTrials.gov · Last updated 23 Mar 2026
Brief summary (registry, in English)
The purpose of the study is the prospective and standardized data collection of patients treated with ion therapy at MedAustron.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 2800 (estimated)
- First submitted
- 13 Jan 2017
- Start date
- 1 Dec 2016
- Primary completion date
- 31 Dec 2031
- Lead sponsor
- EBG MedAustron GmbH
- Diseases
- Childhood cancers
- NCT number
- NCT03049072
What you commit to
- Study type: Observational
- Planned participants: 2800
- From 1 Dec 2016 to the primary completion date, 31 Dec 2031
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Comorbidities endangering treatment delivery or study compliance
Who the study is looking for
- Patients with tumor disease treated with ion beam therapy at MedAustron
- Signed informed consent form
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| EBG MedAustron GmbH Coordinator of this site? Confirm its status | Wiener Neustadt | Austria | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.